Lehti K, Lohi J, Valtanen H, Keski-Oja J
Department of Virology, The Haartman Institute, P.O. Box 21, University of Helsinki, FIN-00014 Helsinki, Finland.
Biochem J. 1998 Sep 1;334 ( Pt 2)(Pt 2):345-53. doi: 10.1042/bj3340345.
Human fibroblasts and HT-1080 fibrosarcoma cells express membrane-type-1 matrix metalloproteinase (MT1-MMP), the cell surface activator of gelatinase A, in separate forms of 63 kDa, 60 kDa and in some cases 43 kDa. In the present work the interrelationships between MT1-MMP processing and gelatinase A activation were analysed using HT-1080 fibrosarcoma cells as a model. It was found that MT1-MMP was synthesized as a 63 kDa protein, which was constitutively processed to a 60 kDa active enzyme with N-terminal Tyr112, as shown by immunoprecipitation, immunoblotting and sequence analyses. Co-immunoprecipitation results indicated that only the active 60 kDa form of MT1-MMP bound gelatinase A at the cell surface. Both the activation of pro-MT1-MMP and the membrane binding of the tissue inhibitor of metalloproteinases type 2 (TIMP-2) and gelatinase A, and subsequent activation of gelatinase A, were inhibited by calcium ionophores. Although the active MT1-MMP was required for cell surface binding and activation of gelatinase A, it was inefficient in activating gelatinase A in fibroblasts or in control HT-1080 cells alone. Low expression levels of TIMP-2 and rapid synthesis of MT1-MMP were found to be critical for gelatinase A activation. In HT-1080 cells, MT1-MMP was further processed to an inactive, 43 kDa cell surface form when overexpressed, or when the cells were treated with PMA. Under these conditions, the activated gelatinase A was detected in the culture medium, in cell membrane extracts and in MT1-MMP-containing complexes. These results indicate that proteolytic processing (activation and degradation/inactivation) of MT1-MMP and MT1-MMP/TIMP-2 relationships at the cell surface are important regulatory levels in the control of gelatinolytic activity.
人成纤维细胞和HT - 1080纤维肉瘤细胞表达膜型1基质金属蛋白酶(MT1 - MMP),它是明胶酶A的细胞表面激活剂,以63 kDa、60 kDa以及某些情况下43 kDa的不同形式存在。在本研究中,以HT - 1080纤维肉瘤细胞为模型分析了MT1 - MMP加工与明胶酶A激活之间的相互关系。结果发现,MT1 - MMP以63 kDa蛋白的形式合成,通过免疫沉淀、免疫印迹和序列分析表明,它被组成性加工为具有N端Tyr112的60 kDa活性酶。共免疫沉淀结果表明,只有活性60 kDa形式的MT1 - MMP在细胞表面与明胶酶A结合。钙离子载体抑制了前MT1 - MMP的激活、金属蛋白酶组织抑制剂2(TIMP - 2)和明胶酶A的膜结合以及随后明胶酶A的激活。尽管活性MT1 - MMP是明胶酶A细胞表面结合和激活所必需的,但它单独在成纤维细胞或对照HT - 1080细胞中激活明胶酶A的效率较低。发现TIMP - 2的低表达水平和MT1 - MMP的快速合成对明胶酶A的激活至关重要。在HT -